CohBar company info

What does CohBar do?
CohBar (NASDAQ:CWBR) is a biotechnology company focused on the research and development of mitochondria-based therapeutics (MBTs), an innovative class of drugs intended to treat diseases associated with aging and metabolic dysfunction. The company's pipeline includes projects aimed at tackling a wide range of conditions, including obesity, type 2 diabetes, cancer, and cardiovascular diseases, by leveraging the therapeutic potential of mitochondrial-derived peptides (MDPs). With a mission to extend healthy lifespan and improve the quality of life, CohBar's ongoing research and development activities underscore its commitment to pioneering the exploration of mitochondria's role in health and disease.
CohBar company media
Company Snapshot

Is CohBar a public or private company?


How many people does CohBar employ?


What sector is CohBar in?

pie chart
Health Care

Where is the head office for CohBar?

location pin
Head Office
Menlo Park, United States

What year was CohBar founded?

founded flag
Year Founded
What does CohBar specialise in?
/Mitochondrial Peptides /Therapeutic Development /Age-related Diseases /Drug Discovery /Metabolic Diseases /Cancer Therapies

What are the products and/or services of CohBar?

Overview of CohBar offerings
Mitochondria based therapeutics for age-associated diseases, focusing on metabolic disorders.
Development of peptides derived from mitochondria for potential treatment of cancer.
Research into mitochondrial-derived peptides (MDPs) for cardiovascular diseases.
Exploring therapeutic potentials in neurodegenerative diseases with mitochondrial peptides.

Who is in the executive team of CohBar?

CohBar leadership team
  • Dr. Pinchas  Cohen Dean, M.D.
    Dr. Pinchas Cohen Dean, M.D.
    Founder & Member of Scientific Advisory Board
  • Dr. Nir Yacov Barzilai M.D.
    Dr. Nir Yacov Barzilai M.D.
    Founder & Member of Scientific Advisory Board
  • Dr. John M. Amatruda M.D., Ph.D.
    Dr. John M. Amatruda M.D., Ph.D.
  • Ms. Jordyn  Tarazi
    Ms. Jordyn Tarazi
    Director of Investor Relations